DIA Europe 2019 has ended
avatar for Julia Stingl

Julia Stingl

Vice President and Head of Research
Julia C Stingl (formerly Kirchheiner) M.D. is professor of translational pharmacology at the University Bonn Medical Faculty and head of the research division of the Federal Institute of Drugs and Medical Devices. Since 2014 she is Vice President of the institute. Her research mostly focuses on understanding individual variability in beneficial and adverse effects of xenobiotics and the translation of this knowledge in a patient-tailored drug therapy. She developed dose adjustments based on pharmacogenetic polymorphisms promoting the way of pharmacogenetics from bench to bedside. She has more than 180 pubmed-listed publications, and an H-index of 41 (ISI web of science, October 2016).

My Speakers Sessions

Wednesday, February 6

12:00 CET